Mexico · Delayed Price · Currency is MXN Amgen Statistics
Total Valuation
Amgen has a market cap or net worth of MXN 3.62 trillion. The enterprise value is 4.42 trillion.
| Market Cap | 3.62T |
| Enterprise Value | 4.42T |
Important Dates
The last earnings date was Tuesday, February 3, 2026.
| Earnings Date | Feb 3, 2026 |
| Ex-Dividend Date | Feb 13, 2026 |
Share Statistics
| Current Share Class | 539.07M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.19% |
| Shares Change (QoQ) | +0.18% |
| Owned by Insiders (%) | 0.15% |
| Owned by Institutions (%) | 81.77% |
| Float | 537.72M |
Valuation Ratios
The trailing PE ratio is 26.05 and the forward PE ratio is 17.20.
| PE Ratio | 26.05 |
| Forward PE | 17.20 |
| PS Ratio | 5.47 |
| PB Ratio | 23.20 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 24.80 |
| P/OCF Ratio | 20.17 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.07, with an EV/FCF ratio of 30.32.
| EV / Earnings | 31.85 |
| EV / Sales | 6.92 |
| EV / EBITDA | 15.07 |
| EV / EBIT | 21.97 |
| EV / FCF | 30.32 |
Financial Position
The company has a current ratio of 1.14, with a Debt / Equity ratio of 6.40.
| Current Ratio | 1.14 |
| Quick Ratio | 0.73 |
| Debt / Equity | 6.40 |
| Debt / EBITDA | 3.29 |
| Debt / FCF | 6.84 |
| Interest Coverage | 3.66 |
Financial Efficiency
Return on equity (ROE) is 106.10% and return on invested capital (ROIC) is 18.12%.
| Return on Equity (ROE) | 106.10% |
| Return on Assets (ROA) | 7.93% |
| Return on Invested Capital (ROIC) | 18.12% |
| Return on Capital Employed (ROCE) | 17.78% |
| Weighted Average Cost of Capital (WACC) | 6.43% |
| Revenue Per Employee | 21.00M |
| Profits Per Employee | 4.41M |
| Employee Count | 31,500 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 1.62 |
Taxes
In the past 12 months, Amgen has paid 22.77 billion in taxes.
| Income Tax | 22.77B |
| Effective Tax Rate | 14.09% |
Stock Price Statistics
The stock price has increased by +3.02% in the last 52 weeks. The beta is 0.47, so Amgen's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | +3.02% |
| 50-Day Moving Average | 5,694.26 |
| 200-Day Moving Average | 5,260.13 |
| Relative Strength Index (RSI) | 57.70 |
| Average Volume (20 Days) | 859 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.96 |
Income Statement
In the last 12 months, Amgen had revenue of MXN 661.64 billion and earned 138.82 billion in profits. Earnings per share was 256.19.
| Revenue | 661.64B |
| Gross Profit | 468.34B |
| Operating Income | 208.37B |
| Pretax Income | 161.60B |
| Net Income | 138.82B |
| EBITDA | 299.16B |
| EBIT | 208.37B |
| Earnings Per Share (EPS) | 256.19 |
Balance Sheet
The company has 164.35 billion in cash and 998.01 billion in debt, with a net cash position of -833.66 billion.
| Cash & Cash Equivalents | 164.35B |
| Total Debt | 998.01B |
| Net Cash | -833.66B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 155.87B |
| Book Value Per Share | 289.29 |
| Working Capital | 64.24B |
Cash Flow
In the last 12 months, operating cash flow was 179.28 billion and capital expenditures -33.45 billion, giving a free cash flow of 145.83 billion.
| Operating Cash Flow | 179.28B |
| Capital Expenditures | -33.45B |
| Free Cash Flow | 145.83B |
| FCF Per Share | n/a |
Margins
Gross margin is 70.78%, with operating and profit margins of 31.49% and 20.98%.
| Gross Margin | 70.78% |
| Operating Margin | 31.49% |
| Pretax Margin | 24.42% |
| Profit Margin | 20.98% |
| EBITDA Margin | 45.22% |
| EBIT Margin | 31.49% |
| FCF Margin | 22.04% |
Dividends & Yields
This stock pays an annual dividend of 178.19, which amounts to a dividend yield of 2.80%.
| Dividend Per Share | 178.19 |
| Dividend Yield | 2.80% |
| Dividend Growth (YoY) | 2.35% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 66.45% |
| Buyback Yield | -0.19% |
| Shareholder Yield | 2.62% |
| Earnings Yield | 3.84% |
| FCF Yield | 4.03% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Amgen has an Altman Z-Score of 1.65 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.65 |
| Piotroski F-Score | 7 |